Work

Comparison between the outcome of metastatic RCC patients treated with sunitinib as part of clinical trials and matched nonparticipants receiving sutent as standard therapy.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.e15597

Authors: Raanan Berger, Maya Ish-Shalom, Natalie Maimon, Maya Gottfried, Roberto Pili, Hans J. Hammers, Mario A. Eisenberger, Victoria J. Sinibaldi, Ben Boursi, Rony Weitzen, Henry Hayat, Avivit Peer, Avivit Neumann, Svetlana Kovel, Avishay Sella, Wilmosh Mermershtain, Keren Rouvinov, Michael Anthony Carducci, Daniel Keizman

Institutions: Tel Aviv University, Meir Medical Center, Roswell Park Comprehensive Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, Sheba Medical Center, Wolfson Medical Center, Rambam Health Care Campus, Assaf Harofeh Medical Center, Soroka Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2615502736

Cites:

Cited by:

Related to: 10